1 recruiting. .
Follow Fianlimab + Cemiplimab: new trials by email Literature Review of Fianlimab + Cemiplimab trials Research Report on Fianlimab + Cemiplimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma Fianlimab + Cemiplimab, Relatlimab + Nivolumab - Locally Advanced Melanoma | Recruiting | John Kirkwood | 20 | 2025-11-19 | 2025-11-26 |
John Kirkwood (1)
United States (1)